Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

5.2%

7 terminated/withdrawn out of 134 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

22%

30 trials in Phase 3/4

Results Transparency

20%

14 of 70 completed trials have results

Key Signals

14 recruiting14 with results

Enrollment Performance

Analytics

N/A

46(46.0%)

Phase 4

22(22.0%)

Phase 2

16(16.0%)

Phase 3

8(8.0%)

Phase 1

8(8.0%)

100Total

N/A(46)

Phase 4(22)

Phase 2(16)

Phase 3(8)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (134)

Showing 20 of 134 trials

NCT07638683Phase 2Recruiting

A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).

Role: collaborator

NCT07740486Phase 3Not Yet Recruiting

A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease

Role: collaborator

NCT07738887Phase 2Not Yet Recruiting

Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 Alterations

Role: collaborator

NCT07649525Phase 3Recruiting

Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level

Role: collaborator

NCT04186000Phase 2Completed

Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola

Role: collaborator

NCT07696975Not ApplicableNot Yet Recruiting

RELIEVE-HFrEF TRIAL: REducing Lung congestIon Symptoms Using the v-wavE Shunt in adVancEd Heart Failure With Reduced EF

Role: collaborator

NCT07534462Not Yet Recruiting

Echocardiographic Assessment of the Effect of Impella on Biventricular Function

Role: collaborator

NCT07655479Recruiting

Rapid Microaxial Flow Pump Support and Escalation in Patients With Myocardial Infarction Associated Cardiogenic Shock and Persistent Need of Hemodynamic Support

Role: collaborator

NCT07254455Not ApplicableNot Yet Recruiting

CASTLE-HFpEF (Catheter Ablation for Atrial Fibrillation Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction)

Role: collaborator

NCT06993675Phase 2Recruiting

Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)

Role: collaborator

NCT07551856Not ApplicableNot Yet Recruiting

Manual Arthroplasty Versus VELYS Robotic-Assisted Solution Functional Alignment Arthroplasty for Knee Osteoarthritis

Role: collaborator

NCT06965504Not ApplicableNot Yet Recruiting

INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery